维普中文期刊产品整合服务
43篇 您的检索式:作者名="LAMBA JK"
    题名 作者 年代 出处 被引量
1Common allelic variants of cytochrome P4503A4 and their prevalence in different populations 显示文摘Lamba JK Lin YS Thummel K 2002Pharmacogenetics2002,12,:1
2Common allelic variants ofcytochrome P4503A4 and their prevalence in different populations 显示文摘Lamba JK Lin YS Thummel K 2002Pharmacogenetics2002,12,2:1
3A therapeutic trial of decitabine and vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia显示文摘Burke MJ Lamba JK Pounds S 2014Am J Hema- tol2014,89,9:1
4Common allelic variants of cytochrome P4503A4 and their prevalence in different populations显示文摘Lamba JK Lin YS Thummel K 2002Pharmacogenetics2002,12,2:1
5Genetic contribution to variable human CYP3A-mediated metabolism显示文摘Lamba JK Lin YS Schuetz EG 0,,:1
6Common allelic variants of cytochrome P4503A4 and their prevalence in different populations 显示文摘Lamba JK Lin YS Thununel K 2002Pharmacogenetics2002,12,2:1
7Genetic contribution to variable human CYP3A-mediated metabolism显示文摘Lamba JK Lin YS Schuetz EG 2002Adv Drug Deliv Rev2002,54,10:1
8G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 ( MDR1 ) expression 显示文摘Song P Lamba JK Zhang L 2006J Clin Pharmacol2006,46,3:1
9Common allelic variants of cytochrome P4503A4 and their prevalence in different populations显示文摘Lamba JK Lin YS Thurmnel K 2002Pharmacogenetics2002,12,:1
10Valproic acidpathway: pharmacokinetics and pharmacodynamics 显示文摘Ghodke-Puranik Y Thom CF Lamba JK eZ al 2013Phar-macog Genom2013,23,4:1
11A therapeutic trial of decitabineand vorinostat in combination with chemotherapy for relapsed/refractory acute lymphoblastic leukemia显示文摘Burke MJ Lamba JK Pounds S 2014Am J Hematol2014,89,:1
12Identification of pre- dictive markers of eytarahine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes 显示文摘Lamba JK Crews KR Pounds SB 2011Pharmacogenomics2011,12,3:1
13Genetic variations in calicheamicin pathway genes are predictors of gemtuzumab ozogamicin response in AML patients: results from COG-AAML0531 study 显示文摘Lamba JK Chauhan L Aplenc R 2015Blood2015,126,23:1
14Genetic contribution to variable human CYP3A mediated metabolism显示文摘Lamba JK Lin YS Schuetz EG 2002Adv Drug Deliv Rev2002,54,10:1
15Genetic contribution to variable human CYP3A-mediatod metabolism显示文摘Lamba JK Lin YS Schuetz EG 2002Adv Drug Deliv Rev2002,54,10:1
16Common allelic variants of cytochrome P4503A4 and their prevalence in different populations显示文摘Lamba JK Lin YS Thummel K 2002Pharmacogenetics2002,12,2:1
17Common allelic variants of cytochrome P4503A4 and their prevalence in different populations显示文摘Lamba JK Lin YS Thummel K Daly A Watkins PB Strom S 2002Pharmacogenetics2002,12,:1
18Pharmacogenetics of deoxycytidine kinase:identification and characterization of novel genetic variants显示文摘Lamba JK Crews K Pounds S 2007J Pharmacol Exp Ther2007,323,3:1
19Valproic acid pathway : pharmacokinetics and pharmacodynamics 显示文摘Ghodke-Puranik Y Thom CF Lamba JK 2013Pharmacogenet Genom2013,23,4:1
20Genetic contribution to variable humari CYP3A-modiated metabolism显示文摘Lamba JK Lin YS Schuetz EG 2002Adv Drug Deliv Rev2002,54,10:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费